11/27/2023 | EULM | Fresenius sets final redemption price for 4% notes due 2024
|
11/3/2023 | EULM | Fresenius to redeem €450 million 4% notes due 2024 on Dec. 4
|
8/25/2023 | BKIG | Fitch revises Fresenius view to stable
|
2/27/2023 | BKHYIG | Fitch places Fresenius Medical on watch
|
2/24/2023 | BKCVHYIG | S&P moves Fresenius SE view to negative
|
2/24/2023 | BKCVHYIG | S&P cuts Fresenius Medical Care
|
11/15/2022 | CVIG | Fitch moves Fresenius view to negative
|
2/1/2021 | HYLM | Fresenius seeks to amend reporting guidelines under 4% notes due 2024
|
4/18/2019 | BKCVIG | Fitch affirms Fresenius
|
12/27/2017 | BKCVHYIG | S&P changes Fresenius view
|
8/23/2017 | BKCVHYIG | S&P ups Fresenius notes to BBB-
|
3/23/2017 | BKHYIG | Fitch: Fresenius notes BBB-
|
2/2/2017 | CV | Fresenius sets conversion price for 0% seven-year convertibles, up 45%
|
1/19/2017 | CV | New Issue: Fresenius sells €500 million 0% seven-year convertibles at minus 0.142% yield
|
1/19/2017 | CV | Fresenius selling €500 million seven-year equity-neutral convertibles to fund acquisition
|
9/7/2016 | BK | S&P puts IDCSalud on positive watch
|
7/29/2016 | BKHYIG | Fitch lifts Fresenius from junk
|
11/16/2015 | BKHYIG | Moody’s upgrades Fresenius, subsidiaries to Baa3
|
9/21/2015 | BKHY | S&P gives BB+ to Fresenius notes
|
9/18/2015 | HY | Market Commentary: Primary ends $976 million week quietly; recent deals firm but Frontier lags; Cablevision slides more
|
9/18/2015 | BKCVDDEMIGPV | Market Commentary: Primary ends $976 million week quietly; recent deals firm but Frontier lags; Cablevision slides more
|
9/17/2015 | HY | Market Commentary: New Berry, Fresenius bonds firmer; Cablevision slides on Altice news; funds gain $236 million
|
9/17/2015 | BKCVDDEMIGPV | Market Commentary: New Berry, Fresenius bonds firmer; Cablevision slides on Altice news; funds gain $236 million
|
9/16/2015 | BKCVDDEMIGPV | Market Commentary: Berry, Fresenius drive by; Sprint, Frontier under pressure; oil names gain on crude rally
|
9/16/2015 | HY | Market Commentary: Berry, Fresenius drive by; Sprint, Frontier under pressure; oil names gain on crude oil rally
|
9/16/2015 | HY | New Issue: Fresenius prices $300 million 7.25-year bullet at par to yield 4½%
|
9/16/2015 | HY | Fresenius talks $300 million 7.25-year bullet to yield in 4½% area; pricing Wednesday
|
9/10/2015 | HY | Market Commentary: Frontier moves up timing, Lyon sells small deal; XPO falls on Con-Way bid; Basic Energy declines
|
9/10/2015 | HY | Fresenius sets Monday-Tuesday non-deal roadshow via Goldman Sachs
|
3/19/2015 | BKCVHYIG | Fitch lower Fresenius view to stable
|
1/16/2015 | HY | Market Commentary: Dollar primary quiet to close $6 billion week, Europe active; Bombardier off again, Caesars up
|
1/16/2015 | BKCVHYIG | S&P ups Fresenius from junk
|
1/12/2015 | BKCVHY | Moody’s changes Fresenius view to stable
|
10/27/2014 | HY | Market Commentary: Building Materials megadeal, Carrizo add-on drive by; M/I Homes drops out; overall market dull
|
3/26/2014 | BKCV | S&P rates Fresenius convertibles BB+
|
3/26/2014 | HY | &P rates Fresenius convertibles BB+
|
3/18/2014 | CV | New Issue: Fresenius sells upsized €500 million 0% five-year convertibles, up 35%
|
3/18/2014 | CV | Fresenius plans to sell €375 million five-year convertibles to yield 0.1%-0.9%, up 35%
|
2/12/2014 | HY | Market Commentary: CIT Group, Griffon drive by; new CIT paper heavily traded; overall market seen firmer
|
2/11/2014 | HY | Fresenius talks $300 million seven-year notes to yield 41/4%-41/2%, pricing expected Tuesday
|
2/11/2014 | HY | New Issue: Fresenius sells $300 million seven-year notes at par to yield 41/4%
|
2/11/2014 | HY | Market Commentary: Ineos, Stena, Fresenius, BlueLine price as Europeans dominate primary; Sprint paper better
|
2/11/2014 | BKHY | Moody's rates Fresenius notes Ba1
|
2/10/2014 | HY | Fresenius sets Tuesday investor call ahead of $300 million seven-year bullet offer
|
2/10/2014 | HY | Market Commentary: B Communications, Meritor deals price, trade up; overall market seen firm, Caesars paper busy
|
1/28/2014 | BKHY | Moody's rates Fresenius notes Ba1
|
1/8/2014 | HY | Market Commentary: Icahn's giant three-parter prices, along with Sabra Health; new Parker bonds rise, MDC busy
|
1/7/2014 | BKHY | Moody's rates Fresenius notes Ba1
|
1/7/2014 | BKHY | S&P rates Fresenius notes BB+
|
1/6/2014 | HY | Fresenius on roadshow Tuesday for €750 million two-part note offering
|
1/6/2014 | HY | Market Commentary: Icahn shops megadeal; Camac, Summit, Fresenius on tap; Hovnanian expected Tuesday; Verso up
|
11/12/2013 | BK | S&P assigns BBB- to Fresenius loans
|
11/7/2013 | IG | Moody's gives Fresenius facilities Baa3
|
9/17/2013 | BKHY | Moody's changes Fresenius view to negative
|
9/12/2013 | BKHY | Fresenius to use debt to fund €3.07 billion acquisition of hospitals
|
8/6/2013 | BKHY | Moody's changes Fresenius view to positive, rates loan Baa3
|
8/5/2013 | BK | Market Commentary: Reynolds, Pinnacle, Willbros, Fresenius break; Multi Packaging, Tata tweak deadlines
|
8/1/2013 | BK | Fresenius trims $500 million term loan pricing to Libor plus 200 bps
|
8/1/2013 | BK | Market Commentary: Quebecor, Larchmont break; U.S. Renal ups deadline; Fresenius, National Surgical revised
|
7/23/2013 | BK | Market Commentary: ClubCorp frees to trade; Gardner Denver, Springer Science, Harbor Freight Tools tweak deals
|
7/23/2013 | BK | Fresenius launches $500 million term loan at Libor plus 225 bps
|
7/18/2013 | BK | Fresenius readies launch of $500 million term loan for Tuesday
|
6/17/2013 | BKHY | Fitch: Fresenius view to positive
|
3/28/2013 | BKHY | S&P lifts Fresenius view to positive
|
12/20/2012 | BK | Fresenius completes €2.25 billion equivalent facility for refinancing
|
12/11/2012 | BKIG | Moody's rates Fresenius loans Baa3
|
12/10/2012 | BKHY | S&P rates Fresenius loans BBB-
|
10/26/2012 | BK | Fresenius increases term loan A amount to $2.6 billion
|
9/27/2012 | BK | Fresenius to launch $3 billion credit facility in New York on Oct. 5
|
9/6/2012 | BKHY | Moody's affirms Fresenius
|
7/23/2012 | BKHY | Fitch: Fresenius unchanged
|
7/6/2012 | HY | Players see a big week taking shape in the high-yield primary market
|
7/5/2012 | HY | Market Commentary: Junk market quiet; Verso off; Community Health trades on tender news; funds gain $779 million
|
7/3/2012 | BK | Moody's: Fresenius still on review
|
6/21/2012 | BK | Moody's: Fresenius loan Ba1
|
6/18/2012 | BK | S&P: Fresenius loans BBB-; placed on watch
|
6/5/2012 | BK | Market Commentary: Hearthside breaks; Alaska Communications trades up; Jazz, Wastequip, Elo Touch tweak deals
|
5/31/2012 | BK | Market Commentary: AlixPartners retranches, breaks; ResCap, SMG revise deals; EquiPower, Fresenius set talk
|
5/31/2012 | BK | Fresenius talks pro rata at Libor plus 225 bps, sets U.S. launch
|
5/29/2012 | BK | Fresenius expected to launch revolver and two term loans on Thursday
|
5/21/2012 | BKHY | Fresenius outlines long-term debt financing plans for Rhon takeover
|
5/21/2012 | HY | Market Commentary: Generac pulls deal; Consolidated downsizes; AMC up on buyout; DaVita off on acquisition
|
4/30/2012 | BKHY | S&P: Fresenius on watch
|
4/26/2012 | BKHY | Fresenius plans €5.3 billion new loans, bonds for Rhön takeover
|
4/26/2012 | BKHY | Moody's may lower Fresenius
|
4/26/2012 | BKHY | Fitch affirms Fresenius
|
2/27/2012 | BKHY | S&P ups Fresenius, Fresenius Medical, notes
|
8/2/2011 | BKHYPF | Fitch upgrades Fresenius
|
3/15/2011 | BK | Market Commentary: MSCI, Fresenius break; Jo-Ann, MetroPCS tweak deals, free up; Primary faces pulling of loans
|
3/9/2011 | BK | Market Commentary: Dynegy dips on loan issues; Great Point breaks, Fairmount, AVG, Fresenius, IMS tweak deals
|
3/9/2011 | BK | Fresenius sets par offer price on U.S., euro-denominated term loan D
|
3/3/2011 | BK | Fresenius launches U.S. and euro denominated term loan D to investors
|
3/3/2011 | BK | Market Commentary: General Nutrition, Gentiva, Savers free up; JMC, NDS, CB Richard, Global Tel tweak deals
|
8/3/2010 | BKHY | Fitch cuts Fresenius view to positive
|
5/21/2010 | BKCVHY | Moody's: Fresenius outlook stable
|
4/29/2010 | BKHY | S&P: Fresenius view positive
|
3/31/2010 | EM | Fitch affirms Fresenius
|
3/15/2010 | BK | Market Commentary: Fresenius, International Lease break; Lyondell, RE/MAX set price talk; RadNet details emerge
|
3/10/2010 | BK | Market Commentary: Psychiatric Solutions up on buyout bid; Quad/Graphics sets talk; HHI, Diamond Foods ready deals
|
3/8/2010 | BK | Fresenius lowers Libor floor on $996 million, €165 million term loan C to 1.5%
|
3/8/2010 | BK | Market Commentary: Harrah's rises on CMBS amendment; Charter gains; N.E.W. floats OID; Fresenius tweaks deal
|
3/2/2010 | BKHY | S&P gives APP, Fresenius loan BBB-
|
2/22/2010 | BK | Fresenius to launch $996 million, €165 million term loan C on Friday
|
2/22/2010 | BK | Market Commentary: Skype, Great Point Power break; Global Tel tweaks deal; ATI, Prime Healthcare float talk
|
8/17/2009 | BKHY | Fitch rates Fresenius Finance notes BB
|
6/9/2009 | BKHY | S&P cuts Fresenius Medical trust preferreds to 4
|
6/3/2009 | HY | New Issue: Fresenius Finance sells upsized €150 million 5.5% notes due 2016 at 92 to yield 7%
|
5/7/2009 | BKHY | S&P: Fresenius outlook stable
|
2/27/2009 | HY | S&P lifts Fresenius notes' recovery rating to 3
|
1/20/2009 | HY | Market Commentary: Junk market hangs in despite stock slide; Freescale in free-fall; N.Y. Times bonds gyrate after new financing
|
1/16/2009 | HY | Market Commentary: Charter, Smurfit-Stone rebound from lows; Terra takeover bid boosts bonds; sleepless nights for Sealy holders
|
1/15/2009 | HY | New Issue: Fresenius prices $500 million and €275 million in upsized senior notes due 2015
|
1/15/2009 | HY | Market Commentary: Fresenius prices upsized dollar, euro deal, bonds trade up; Charter drops on missed coupon; funds gain $535 million
|
1/14/2009 | HY | Fresenius sets price talk for $500 million and €200 million notes
|
1/14/2009 | HY | Market Commentary: MetroPCS brings upsized deal, bonds trade up; Nortel gyrates on Chapter 11 filing; broad market lower
|
1/13/2009 | HY | Market Commentary: Isle of Capri jumps on partial tender offer; Neiman Marcus off on PIK interest decision; Nortel baffles investors
|
1/12/2009 | HY | Market Commentary: Advanced Medical Optics flies on Abbott bid; Landry's off as CEO withdraw deal; Fresenius shops dollar/euro deal
|
1/12/2009 | BK | Fresenius to repay bridge loan with bond proceeds
|
1/12/2009 | HY | Fresenius marketing up to $650 million six-year bullet notes in bridge refinancing
|
1/12/2009 | HY | S&P gives Fresenius placement BB
|
1/12/2009 | HY | Market Commentary: Advanced Medical Optics flies on Abbott bid; Landry's off as CEO withdraw deal; Fresenius shops dollar/euro deal
|
10/28/2008 | HY | Market Commentary: Stock rally spurs junk upward, GM/GMAC leading; Rent-A-Center gyrates; Apria, Avaya get LBO funding
|
10/2/2008 | BKHY | Moody's cuts Fresenius loan to Baa3
|
9/29/2008 | BKHY | S&P: Fresenius unaffected
|
9/2/2008 | SS | HSR wait ends early in merger of APP Pharmaceuticals, Fresenius
|
8/28/2008 | BKHY | Moody's: Fresenius view negative
|
8/1/2008 | HY | Fresenius sets high-yield bridge size at $1.65 billion; source says entire deal could be dollar denominated
|
8/1/2008 | HY | Market Commentary: GM skids on big loss; Boyd booms on project delay; Elan, Idearc tumble anew; Clear Channel rolls bridge
|
7/31/2008 | BKHY | Fitch: Fresenius unaffected
|
7/30/2008 | BKHY | S&P may cut Fresenius
|
7/9/2008 | BKHY | S&P: Fresenius outlook negative
|
7/7/2008 | BKHY | Moody's may cut Fresenius
|
7/7/2008 | BKHY | Fitch drops Fresenius outlook to negative
|
7/7/2008 | HY | Fresenius to bring $1.5 billion equivalent bonds to help fund acquisition of APP Pharmaceuticals
|
7/7/2008 | SS | Fresenius to acquire APP Pharmaceuticals for $3.7 billion
|
7/31/2007 | BKHY | Fitch affirms Fresenius
|